The Journal of Practical Medicine >
Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence
Received date: 2024-02-21
Online published: 2024-08-26
Diabetes mellitus erectile dysfunction （DMED） is a common diabetic-related vascular， endocrine and neuropathy in clinical practice， and patients with DMED often present with symptoms such as difficulty in erection， prolonged erection time， poor hardness， and short sexual intercourse. The etiological mechanism is complex， and it is often closely related to many factors such as oxidative stress （OS）， inflammatory response， and neurological and endocrine lesions， which often cross-react and promote the progression of DMED lesions. In recent years， relevant studies have shown that OS and ferroptosis play a key role in DMED： OS can cause neurological and Abnormal endocrine function， decreased synthesis or bioavailability of penile vascular endothelium， spongy endothelial cell dysfunction and decreased smooth muscle diastolic function， resulting in penile erectile dysfunction， and ferroptosis has also been confirmed to be closely related to DMED， controlling OS and ferroptosis to improve erectile function in diabetic patients is a reasonable and effective treatment pathway， but the mechanism of action of ferroptosis leading to DMED needs to be further studied. Therefore， this article reviews the latest information on the correlation between OS and ferroptosis and DMED， aiming to provide a useful reference for exploring the mechanism of DMED， clinical prevention and treatment of DMED， and providing potential directions for future research in this field.
Ganggang LU , Shenglong LI , Yongqiang ZHAO , Yunpeng JIA , Yonglin LIANG , Yuanbo. ZHAO . Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence[J]. The Journal of Practical Medicine, 2024 , 40(16) : 2229 -2235 . DOI: 10.3969/j.issn.1006-5725.2024.16.006
| 1 | LI B， HU P， LIU K， et al. MiRNA‐100 ameliorates diabetes mellitus‐induced erectile dysfunction by modulating autophagy， anti‐inflammatory， and antifibrotic effects［J］. Andrology， 2024.doi： 10.1111/andr.13586 . |
| 2 | SUN H， SAEEDI P， KARURANGA S， et al. IDF Diabetes Atlas： Global， regional and country-level diabetes prevalence estimates for 2021 and projections for 2045［J］. Diabetes Res Clin Pract， 2022， 183： 109119. doi:10.1016/j.diabres.2023.110945 |
| 3 | LIU D F， JIANG H， HONG K， et al. Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors［J］. Chin Med J （Engl）， 2010， 123（22）： 3258-3261. |
| 4 | LI K， ZHU A， GUTMAN J， et al. Cysteine-Rich Whey Protein Isolate （CR-WPI） Ameliorates Erectile Dysfunction by Diminishing Oxidative Stress via DDAH/ADMA/NOS Pathway［J］. Oxid Med Cell Longev， 2022， 2022： 8151917. doi:10.1155/2022/8151917 |
| 5 | LI S， ZHENG L， ZHANG J， et al. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy［J］. Free Radic Biol Med， 2021， 162： 435-449. doi:10.1016/j.freeradbiomed.2020.10.323 |
| 6 | LI W， LI W， LENG Y， et al. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress［J］. DNA Cell Biol， 2020， 39（2）： 210-225. doi:10.1089/dna.2019.5097 |
| 7 | ZHU Z， DUAN P， SONG H， et al. Downregulation of Circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p/cofilin-2 axis［J］. Bioengineered， 2021， 12（2）： 12555-12567. doi:10.1080/21655979.2021.2010369 |
| 8 | HAO L， MI J， SONG L， et al. SLC40A1 Mediates Ferroptosis and Cognitive Dysfunction in Type 1 Diabetes［J］. Neuroscience， 2021， 463： 216-226. doi:10.1016/j.neuroscience.2021.03.009 |
| 9 | WANG X， MA H， SUN J， et al. Mitochondrial Ferritin Deficiency Promotes Osteoblastic Ferroptosis Via Mitophagy in Type 2 Diabetic Osteoporosis［J］. Biol Trace Elem Res， 2022， 200（1）： 298-307. doi:10.1007/s12011-021-02627-z |
| 10 | SHAMLOUL R， GHANEM H. Erectile dysfunction［J］. Lancet， 2013， 381（9861）： 153-165. doi:10.1016/s0140-6736(12)60520-0 |
| 11 | LI H， CHEN L P， WANG T， et al. Calpain inhibition improves erectile function in diabetic mice via upregulating endothelial nitric oxide synthase expression and reducing apoptosis［J］. Asian J Androl， 2018， 20（4）： 342-348. doi:10.4103/aja.aja_63_17 |
| 12 | ROYCHOUDHURY S， CHAKRABORTY S， CHOUDHURY A P， et al. Environmental Factors-Induced Oxidative Stress： Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction［J］. Antioxidants （Basel）， 2021， 10（6）： 837. doi:10.3390/antiox10060837 |
| 13 | ZIRKIN B R， CHEN H. Regulation of Leydig cell steroidogenic function during aging［J］. Biol Reprod， 2000， 63（4）： 977-981. doi:10.1095/biolreprod63.4.977 |
| 14 | JEREMY J Y， JONES R A， KOUPPARIS A J， et al. Reactive oxygen species and erectile dysfunction： possible role of NADPH oxidase［J］. Int J Impot Res， 2007， 19（3）： 265-280. doi:10.1038/sj.ijir.3901523 |
| 15 | ZHANG L， HE Y， JIANG Y， et al. PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation［J］. Cell Death Dis， 2023， 14（4）： 233. doi:10.1038/s41419-023-05752-w |
| 16 | GAJECKI D， GAWRYS J， WISNIEWSKI J， et al. A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus［J］. Nutrients， 2021， 13（7）： 2306. doi:10.3390/nu13072306 |
| 17 | HU L L， ZHANG K Q， TIAN T， et al. Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1/ DDAH/PPAR-γ/eNOS pathways in streptozotocin-induced diabetic rats［J］. Biochem Biophys Res Commun， 2018， 507（1/4）： 9-14. doi:10.1016/j.bbrc.2018.10.036 |
| 18 | CHEN D， ZHANG K Q， LI B， et al. Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway［J］. Asian J Androl， 2017， 19（3）： 291-297. doi:10.4103/1008-682x.178486 |
| 19 | SUN T， XU W， WANG J， et al. Saxagliptin alleviates erectile dysfunction through increasing stromal cell‐derived factor‐1 in diabetes mellitus［J］. Andrology， 2023， 11（2）： 295-306. doi:10.1111/andr.13296 |
| 20 | GALHOM R A， KORAYEM H E， IBRAHIM M A， et al. Urine-Derived Stem Cells Versus Their Lysate in Ameliorating Erectile Dysfunction in a Rat Model of Type 2 Diabetes［J］. Front Physiol， 2022， 13： 854949. doi:10.3389/fphys.2022.854949 |
| 21 | VOLPE C M O， VILLAR-DELFINO P H， DOS ANJOS P M F， et al. Cellular death， reactive oxygen species （ROS） and diabetic complications［J］. Cell Death Dis， 2018， 9（2）： 119. doi:10.1038/s41419-017-0135-z |
| 22 | DURAN A M， BEESON W L， FIREK A， et al. Dietary Omega-3 Polyunsaturated Fatty-Acid Supplementation Upregulates Protective Cellular Pathways in Patients with Type 2 Diabetes Exhibiting Improvement in Painful Diabetic Neuropathy［J］. Nutrients， 2022， 14（4）： 761. doi:10.3390/nu14040761 |
| 23 | EISA N H， HELMY S A， EL-KASHEF D H， et al. Pramipexole protects against diabetic neuropathy： Effect on oxidative stress， TLR4/IRAK-1/TRAF-6/NF-κB and downstream inflammatory mediators［J］. Int Immunopharmacol， 2024， 128： 111514. doi:10.1016/j.intimp.2024.111514 |
| 24 | ZHANG L， BAO B， GUO J， et al. Current status and prospects of diabetes mellitus induced erectile dysfunction： A bibliometric and visualization study［J］. Front Endocrinol （Lausanne）， 2023， 14： 1168744. doi:10.3389/fendo.2023.1168744 |
| 25 | PAUL A， KUMAR M， DAS P， et al. Drug repurposing?A search for novel therapy for the treatment of diabetic neuropathy［J］. Biomed Pharmacother， 2022， 156： 113846. doi:10.1016/j.biopha.2022.113846 |
| 26 | ESCOBAR-MORREALE H F， MARTINEZ-GARCIA M A， MONTES-NIETO R， et al. Effects of glucose ingestion on circulating inflammatory mediators： Influence of sex and weight excess［J］. Clin Nutr， 2017， 36（2）： 522-529. doi:10.1016/j.clnu.2016.01.015 |
| 27 | WANG Y， LI J， HUANG Y， et al. Tripartite motif?containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR‐1 and -2 and VEGFR2 in endothelial cells［J］. FASEB J， 2017， 31（5）： 2026-2036. doi:10.1096/fj.201600988rr |
| 28 | NEMKOV T， SUN K， REISZ J A， et al. Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage［J］. Haematologica， 2018， 103（2）： 361-372. doi:10.3324/haematol.2017.178608 |
| 29 | ROJAS D R， TEGEDER I， KUNER R， et al. Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species［J］. J Mol Med （Berl）， 2018， 96（12）： 1395-1405. doi:10.1007/s00109-018-1707-9 |
| 30 | MORELLO E， SUTTI S， FOGLIA B， et al. Hypoxia‐inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine‐rich glycoprotein［J］. Hepatology， 2018， 67（6）： 2196-2214. doi:10.1002/hep.29754 |
| 31 | CAROTA I A， KENIG-KOZLOVSKY Y， ONAY T， et al. Targeting VE-PTP phosphatase protects the kidney from diabetic injury［J］. J Exp Med， 2019， 216（4）： 936-949. doi:10.1084/jem.20180009 |
| 32 | DUCSAY C A， GOYAL R， PEARCE W J， et al. Gestational Hypoxia and Developmental Plasticity［J］. Physiol Rev， 2018， 98（3）： 1241-1334. doi:10.1152/physrev.00043.2017 |
| 33 | JAIN T， NIKOLOPOULOU E A， XU Q， et al. Hypoxia inducible factor as a therapeutic target for atherosclerosis［J］. Pharmacol Ther， 2018， 183： 22-33. doi:10.1016/j.pharmthera.2017.09.003 |
| 34 | PHE V， ROUPRET M. Erectile dysfunction and diabetes： a review of the current evidence-based medicine and a synthesis of the main available therapies［J］. Diabetes Metab， 2012， 38（1）： 1-13. doi:10.1016/j.diabet.2011.09.003 |
| 35 | 刘洋， 孙岳， 杨安宁， 等. 铁死亡参与高脂饮食诱导的ApoE-/-小鼠动脉粥样硬化及ox-LDL诱导的泡沫细胞形成过程［J］. 实用医学杂志， 2021， 37（5）： 585-590. doi:10.3969/j.issn.1006-5725.2021.05.006 |
| 36 | LI W， LI W， WANG Y， et al. Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritinophagy during diabetes myocardial ischemia/reperfusion injury［J］. Cell Death Discov， 2021， 7（1）： 267. doi:10.1038/s41420-021-00656-0 |
| 37 | YAN H F， ZOU T， TUO Q Z， et al. Ferroptosis： mechanisms and links with diseases［J］. Signal Transduct Target Ther， 2021， 6（1）： 49. doi:10.1038/s41392-020-00428-9 |
| 38 | ZHANG S， BEI Y， HUANG Y， et al. Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice［J］. Mol Med， 2022， 28（1）： 121. doi:10.1186/s10020-022-00549-7 |
| 39 | HUANG Z， MA Y， SUN Z， et al. Ferroptosis： potential targets and emerging roles in pancreatic diseases［J］. Arch Toxicol， 2024， 98（1）： 75-94. doi:10.1007/s00204-023-03625-x |
| 40 | STOCKWELL B R， FRIEDMANN ANGELI J P， BAYIR H， et al. Ferroptosis： A Regulated Cell Death Nexus Linking Metabolism， Redox Biology， and Disease［J］. Cell， 2017， 171（2）： 273-285. doi:10.1016/j.cell.2017.09.021 |
| 41 | LUO E F， LI H X， QIN Y H， et al. Role of ferroptosis in the process of diabetes-induced endothelial dysfunction［J］. World J Diabetes， 2021， 12（2）： 124-137. doi:10.4239/wjd.v12.i2.124 |
| 42 | FANG X， ARDEHALI H， MIN J， et al. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease［J］. Nat Rev Cardiol， 2023， 20（1）： 7-23. doi:10.1038/s41569-022-00735-4 |
| 43 | CHEN P， CHEN Z， ZHAI J， et al. Overexpression of PRDX2 in Adipose-Derived Mesenchymal Stem Cells Enhances the Therapeutic Effect in a Neurogenic Erectile Dysfunction Rat Model by Inhibiting Ferroptosis［J］. Oxid Med Cell Longev， 2023， 2023： 4952857. doi:10.1155/2023/4952857 |
| 44 | FENG H， LIU Q， DENG Z， et al. Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis［J］. Stem Cell Res Ther， 2022， 13（1）： 450. doi:10.1186/s13287-022-03147-w |
| 45 | WANG Y， ZHANG X， CHEN Y， et al. Identification of hub biomarkers and exploring the roles of immunity， M6A， ferroptosis， or cuproptosis in rats with diabetic erectile dysfunction［J］. Andrology， 2023， 11（2）： 316-331. doi:10.1111/andr.13265 |
| 46 | XU W， SUN T， WANG J， et al. GPX4 Alleviates Diabetes Mellitus-Induced Erectile Dysfunction by Inhibiting Ferroptosis［J］. Antioxidants （Basel）， 2022， 11（10）： 1896. doi:10.3390/antiox11101896 |
| 47 | DU S， SHI H， XIONG L， et al. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy［J］. Front Endocrinol （Lausanne）， 2022， 13： 1011669. doi:10.3389/fendo.2022.1011669 |
| 48 | 王赛， 高静. 富马酸二甲酯对过氧化氢诱导心脏微血管内皮细胞铁死亡的影响［J］. 实用医学杂志， 2023， 39（12）： 1494-1499. doi:10.3969/j.issn.1006-5725.2023.12.006 |
| 49 | FENG X， WANG S， SUN Z， et al. Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice［J］. Front Endocrinol （Lausanne）， 2021， 12： 626390. doi:10.3389/fendo.2021.626390 |
| 50 | WU Y， ZHAO Y， YANG H Z， et al. HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose［J］. Biosci Rep， 2021， 41（2）： BSR20202924. doi:10.1042/bsr20202924 |
/
| 〈 |
|
〉 |